Skip to main content

Advertisement

Table 5 ICCs and adjusted differences between groups

From: The effectiveness of the Austrian disease management programme for type 2 diabetes: a cluster-randomised controlled trial

  ICC1 district ICC1 surgery adjusted2   
    mean difference 95%-CI p-value
Primary outcome measure
HbA1c (%) -0.002 0.003 -0.03 [-0.15; 0.09] 0.607
Secondary outcome measures
Creatinine (μmol/l) 0.001 -0.001 -0.96 [-4.16; 2.20] 0.545
Triglycerides (mmol/l) -0.002 0.003 -0.10 [-0.24; 0.05] 0.190
Cholesterol (mmol/l) -0.001 0.006 -0.10 [-0.21; -0.003] 0.043
HDL (mmol/l) 0.002 0.048 -0.01 [-0.05; 0.02] 0.438
LDL (mmol/l) 0.007 0.046 -0.02 [-0.10; 0.07] 0.684
RR systolic (mmHg) 0.002 0.054 -0.50 [-2.06; 1.05] 0.524
RR diastolic (mmHg) 0.009 0.045 -0.13 [-1.03; 0.76] 0.770
BMI -0.001 0.020 -0.53 [-1.03; -0.02] 0.040
  1. 1 calculated with GEE
  2. 2 mixed models adjusted for baseline value and cluster structure